⚠️ Disclaimer

PE-22-28 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.

PE-22-28 is Not FDA-approved. Investigational research peptide only. Regulations vary by country, and the legal landscape for peptides is evolving. This guide covers the current legal status and what researchers need to know.

Is PE-22-28 Legal?

Not FDA-approved. Investigational research peptide only.

The legal landscape for peptides like PE-22-28 is nuanced and varies by jurisdiction. This guide covers the current regulatory status and what researchers need to know.

What Is the Legal Status of PE-22-28 in the United States?

PE-22-28 is generally available as a research chemical in the US. It is not FDA-approved for human use, which means it cannot be marketed, sold, or prescribed as a drug or supplement.

However, research chemicals can be legally purchased for laboratory, in vitro, or educational use. The key legal distinction is between personal research use and human consumption — the latter is not approved.

Is PE-22-28 Legal Internationally?

Peptide regulations vary significantly by country. Some jurisdictions classify peptides as prescription-only compounds, while others allow research chemical sales similar to the US.

Australia: Most peptides require a prescription. UK: Generally available for research. Canada: Research chemical status. EU: Varies by country. Always check local regulations before purchasing.

Is PE-22-28 Banned in Sports?

PE-22-28 may be subject to anti-doping regulations depending on its class and mechanism. Athletes should check the current WADA prohibited list.

If you compete in any organized sport, assume all peptides are prohibited unless you have confirmed otherwise with your sport's governing body.

How Is the Legal Landscape Changing?

Peptide regulation is an evolving area. The FDA has increased scrutiny of compounding pharmacies and research chemical vendors in recent years. Some peptides that were freely available have faced new restrictions.

Staying informed about regulatory changes is important for researchers working with PE-22-28 and similar compounds.

Bottom Line on PE-22-28 Legality

Not FDA-approved. Investigational research peptide only. Researchers should ensure compliance with their local laws and use PE-22-28 only for legitimate research purposes.

Complete Guide

PE-22-28 : Benefits, Dosage, Side Effects & Research

Read the Full Guide →

Related Reading

Calculate Your PE-22-28 Dose

Use our free peptide dosing calculator to get exact reconstitution math and syringe units for PE-22-28.

Open Calculator →

Research-Grade Sourcing

If you're going to research PE-22-28, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.

Limitless → Browse PE-22-28

Frequently Asked Questions

What is PE-22-28?

PE-22-28 (PE-22-28 (spadin analog, TREK-1 inhibitor)) is a Ion channel inhibitor peptide. Synthetic shortened analog of spadin with enhanced TREK-1 potassium channel specificity and brain stability. It is researched for rapid antidepressant effects (4 days vs 4-6 weeks for SSRIs), hippocampal neurogenesis, enhanced synaptogenesis.

What is the recommended PE-22-28 dosage?

Common dosages: 100-500 mcg daily administered once daily via subcutaneous injection (proposed). Cycle length: 4-8 weeks. Half-life: 14-23 hours in rodents. Use our peptide calculator for exact reconstitution math.

What are the side effects of PE-22-28?

Minimal toxicity in animal models. Potential hypertension from enhanced monoamine activity. Human safety unknown. GABAergic disruption possible.

Is PE-22-28 safe?

PE-22-28 has shown a preliminary safety profile in research. Not FDA-approved. Investigational research peptide only. All research should follow appropriate safety protocols.